Women were less than half of the people tested for almost all of these common medicines.

NCT02188121

Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

See it on ClinicalTrials.gov ↗

204 people

81 womenmiddle line = equal numbers123 men
Phase
PHASE4
Paid for by
Mclean Hospital
Finished
2021-10
Health conditions
Serious Mental Illness, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Cardiovascular Disease, Major Depressive Disorder, Psychosis NOS
Who could join
Anyone
Ages
18 Years – 89 Years
Average age
mean 37.2 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
White 71.1% · Black / African American 16.7% · Not reported 5.9% · More than one race 3.4% · Asian 2.5% · American Indian / Alaska Native 0.5% · Native Hawaiian / Pacific Islander 0%

Women left out

  • No pregnant women

    Women who were pregnant could not join.

    “…y medications, e.g., diabetes, unstable angina or recent acute coronary syndrome, pregnancy, very high risk factors on the screening labs (e.g., A1c\>7%), renal failure, liver failure, or both statin and angiotension drug contraindications.”
  • No kidney or liver problems

    Women with kidney or liver problems were turned away.

    “…y medications, e.g., diabetes, unstable angina or recent acute coronary syndrome, pregnancy, very high risk factors on the screening labs (e.g., A1c\>7%), renal failure, liver failure, or both statin and angiotension drug contraindications.”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    “…tential contraindications with both study medications, e.g., diabetes, unstable angina or recent acute coronary syndrome, pregnancy, very high risk factors on the screening labs (e.g., A1c\>7%), renal failure, liver failure, or both statin…”
  • No diabetes

    Women with diabetes were turned away.

    “…ctive disease or potential contraindications with both study medications, e.g., diabetes, unstable angina or recent acute coronary syndrome, pregnancy, very high risk factors on the screening labs (e.g., A1c\>7%), renal failure, liver failu…”

Study titles and rules are shown in their original English.